Dr. Christine Desbiens is a surgeon-oncologist at the CHU de Québec-Laval University. She is also a clinical researcher at the Research Center of the CHU de Québec-Université Laval and clinical professor at the Faculty of Medicine of Laval University. Dr. Desbiens is part of the research group of the Centre des Maladies du Sein of CHU de Québec-Laval University.
Dr. Desbiens is the leader of the Canadian Clinical Trial Group at Saint-Sacrement Hospital of the CHU de Québec. She is also the medical director for the Centre des Maladies du Sein du CHU de Québec.
Using structured breast cancer data
The Centre des Maladies du Sein research team has a comprehensive database of all cancers diagnosed since 1974; more than 12,000 patients are listed. A database of biopsy data from 1999 is also available; data on more than 34,000 biopsies are listed. These databases allow quality publications that modify the management and management of cancers and benign breast diseases.
Offer innovative treatments
The research group of the Centre des Maladies du Sein of the CHU de Québec-Laval University is one of the largest research groups in Canada offering innovative treatments for breast cancer. More than 50 clinical trials are active at all times, and are offered to patients who consult at the clinic or are referred by clinics/hospitals in the area. These clinical trials provide access to innovative experimental medications and develop the expertise of our world-renowned oncologists.
Support the quality of life
The Centre des Maladies du Sein of the CHU de Québec-Laval University research group is a pioneer in quality of life studies in breast cancer, from total mastectomy to partial mastectomy, to the use of the cooling cap to counteract hair loss, promoting physical activity to improve survivorship, including optimal preservation of the axillary lymph nodes. The research group is at the forefront of studies promoting quality of life, despite the disease’s life trial.
1050, chemin Sainte-Foy
Centre des maladies du sein Deschênes-Fabia
Québec, Québec
Canada G1S 4L8
Latest news
Data not available
Evaluation of eligibility and recruitment in breast cancer clinical trials
Journal ArticleBreast, 23 (4), 2014.
Abstract | Links: 
1ère édition : Qualité de vie après une mastectomie prophylactique (2013). Édition 2014 révisée par Bouchard K et Drolet AM
BookCHU de Québec et Centre des maladies du sein Deschênes-Fabia, Québec, 2014.
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients
Journal ArticleAnn Pharmacother, 48 (4), 2014.
Abstract | Links:
[Multidisciplinary clinical management for prophylactic mastectomy: views of women from one centre in Quebec City]
Journal ArticleBull Cancer, 100 (3), 2013.
Abstract | Links:
Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment
Journal ArticleClin Trials, 9 (5), 2012.
Abstract | Links:
Self-reported mammography use following BRCA1/2 genetic testing may be overestimated
Journal ArticleFam Cancer, 11 (1), 2012.
Abstract | Links:
Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy
Journal ArticleRadiology, 263 (1), 2012.
Abstract | Links:
Primary breast angiosarcoma: avoiding a common trap
Book2011.
Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up
Journal ArticleBreast Cancer Res Treat, 128 (2), 2011.
Abstract | Links:
Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy
Journal ArticleBreast, 20 (1), 2011.
Abstract | Links:
Active projects
- COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib , from 2024-03-12 to 2029-12-25
- From survival to quality of life: developing and implementing priorities- and values-based personalized supportive and rehabilitation care pathways with and for people with advanced breast cancer, from 2024-07-15 to 2024-10-15
- NSABP Breast Cancer Treatment Protocols, from 1997-02-01 to 2025-12-25
- OptimICE-pCR: De-escalation of Therapy in Early-Stage TNBC Patients who Achieve pCR after Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy , from 2024-04-26 to 2025-02-28
- Vers des trajectoires de soins en cancer du sein personnalisées en fonction du risque et des besoins des patientes: une étude de faisabilité et d'acceptabilité, from 2023-04-01 to 2025-03-31
Recently finished projects
- Exploring the impact for COVID-19 pandemic on women with breast cancer in Quebec, from 2021-12-01 to 2023-09-30
- Tomosynthesis Mammographic Imaging Screening Trial (TMIST), from 2017-09-11 to 2022-12-25